Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100

Zimmer Biomet Holdings, Inc. (ZBH) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a P/B ratio of 1.4×. Over the past ten years it has ranged from 1.2× (May 2026) to 3.0× (February 2015); the current reading is higher than 6% of that period. That is below the Medical Devices industry median of 2.3× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.4× (18.51%)
FY2024 1.7× (15.23%)
FY2023 2.0× (8.55%)
FY2022 2.2× 9.20%
FY2021 2.0× (19.98%)
FY2020 2.5× 5.55%
FY2019 2.4× 32.34%
FY2018 1.8× (12.30%)
FY2017 2.1× (0.13%)
FY2016 2.1× 9.93%

Quarterly newest first

Period P/B ratio Change
Jun 2026 1.3× (5.80%)
Mar 2026 1.4× (0.78%)
Dec 2025 1.4× (8.32%)
Sep 2025 1.5× 6.14%
42 more quarters

Against its own ten years

Low 1.2× High 3.0×
Ten-year median 2.1×
Current reading's percentile 7

P/B ratio against peers

Company P/B ratio
BIO.B Bio-Rad Laboratories, Inc. compare 1.4×
ZBH Zimmer Biomet Holdings, Inc. 1.4×
PHG Koninklijke Philips N.V. compare 1.8×
GMED Globus Medical, Inc. compare 2.2×
SNN Smith & Nephew SNATS, Inc. compare 2.5×
GEHC GE HealthCare Technologies Inc. compare 2.9×
STE STERIS plc compare 3.0×
PEN Penumbra, Inc. compare 8.2×
DXCM DexCom, Inc. compare 12.5×
Medical Devices industry median 2.3×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ZBH